Shares of Medical Properties Trust (MPW) soared over 5% in pre-market trading on Friday, following actions from analysts covering the healthcare real estate investment trust (REIT).
BofA analyst Joshua Dennerlein lowered the firm's price target on MPW to $3 from $3.50, but maintained an Underperform rating on the stock. While a price target cut typically weighs on a stock, the relatively modest reduction may not have had a significant impact in this case.
Meanwhile, a separate analysis from Zacks Investment Research highlighted some key factors that could be driving investor interest in MPW. The report noted MPW's attractive valuation compared to peers, as reflected in its Value Style Score of C, indicating the stock is trading roughly in line with the industry average.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。